Skip to main content
Full access
Letter to the Editor
Published Online: 13 March 2024

Reduction in Trauma-Related Symptoms After Anesthetic-Induced Intra-Operative Dreaming

Publication: American Journal of Psychiatry
​To the Editor: While dreaming during anesthesia is common (1), it is not known whether this phenomenon differs from normal dreaming or has post-surgical benefits. We present two cases of female patients who experienced rapid and sustained reduction of posttraumatic stress disorder (PTSD) symptoms immediately following anesthetic-based EEG-guided intraoperative dream induction. Both patients underwent surgeries and received propofol/opioid-based anesthetics. Upon finishing the surgery but before emergence, we maintained a pre-emergent anesthetic state characterized by specific frontal cortical activity for several minutes: reduced alpha power and enhanced beta power (2). Based on previous findings showing that dreaming during anesthesia is associated with more high-frequency frontal power before emergence (3) or as compared to connected consciousness (1), we believe this cortical activity reflects dreaming while being sedated. Patients were interviewed immediately upon emergence, and both reported having had vivid dreams.
Both patients were identified as part of a quality-improvement program to enhance recovery after surgery, which includes informing patients of the possibility of dreaming without priming content, minimizing likelihood of emergence agitation through use of intravenous rather than inhalational anesthesia, minimal sensory input during gradual anesthetic emergence (4), and assessment for intraoperative awareness and dreaming immediately on emergence using a modified Brice Questionnaire (5). After identification, both patients provided informed consent for retrospective psychiatric diagnostic interviews. Patients were not identified preoperatively. Anesthetic adjustments, assessment, and diagnostic interviews adhere to established standards of care, received approval from the IRB, or fall under IRB exemption (IRB exempt protocols #54043, #59783, #65538, #67245; informed consent provided on IRB protocol #67399).
Patient 1, a 57-year-old White female with no current alcohol, tobacco, or drug use and noncontributory medical history except invasive ductal carcinoma of the right breast, presented for a right breast lumpectomy and axillary lymph node biopsy. She was not taking psychiatric medications at the time of surgery. She endorsed one nightmare per week about her son, who had died by suicide in 2017. She recalled two “euphoric” intra-operative dreams: in one, she experienced her son’s birth, originally traumatic, as deeply joyful; in a second, she spent time with her adult son and experienced cathartic relief. The Clinician-Administered PTSD Scale for DSM-5 (CAPS-5) indicated a diagnosis of PTSD pre-operatively. One-month post-surgery, she no longer met criteria for PTSD, and by 1 year, she had remitted. Self-report scales indicated improvement in depression, anxiety, and sleep (Figure 1). The patient reported that she has not had a nightmare “in over 18 months” and that her experience during surgery “saved her life.”
FIGURE 1. Retrospective symptom ratings after dreaming associated with anesthesiaa
aDiagnostic interviews for PTSD were performed at 38 and 324 days (patient 1) and 25 days (patient 2) after the surgical encounter. From left to right, symptom scales for PTSD (Clinician-Administered PTSD Scale [CAPS-5], depression (Patient Health Questionnaire, eight items [PHQ-8]), Generalized Anxiety Disorder, seven items [GAD-7]), and sleep quality (Pittsburgh Sleep Quality Index [PSQI]). Retrospective ratings are indicated by open symbols, current ratings are indicated by closed symbols. Day of surgery indicated on x-axis, orange line. Remission threshold for each scale indicated on y-axis, dashed red line.
Patient 2, a 72-year-old White female with no reported alcohol, tobacco, or drug use and noncontributory medical history except hyperparathyroidism, presented for parathyroidectomy. She was taking fluoxetine for anxiety and depression at the time of surgery. She reported occasional nightmares about her son in the month pre-surgery, who died in 2000 from alcohol poisoning during a college fraternity hazing. Intra-operatively, she dreamed about being with her late son and other family members and described the dream as “very positive.” CAPS-5 assessment indicated that she met criteria for PTSD in the month pre-surgery but not in the month post-surgery, and self-report scales for anxiety and depression showed improvement (Figure 1). She denied nightmares in the month post-surgery.
Anesthetic-induced prolonged dream states may serve as an emotion regulation function. Patients experiencing fear memory elements (i.e., dreaming about their sons) on a background of anesthetic-induced low arousal may have contributed to fear extinction (6). We recently presented a case of resolution of acute stress disorder (2) after anesthetic-induced intra-operative dreaming. These collected cases suggest that anesthetic-induced intra-operative dreaming may be therapeutic in both recent onset and long-standing trauma disorders and have a rapid and durable effect. This preliminary evidence justifies an open-label study of deliberate induction of dreaming with anesthesia in PTSD.

References

1.
Casey CP, Tanabe S, Farahbakhsh Z, et al: Distinct EEG signatures differentiate unconsciousness and disconnection during anaesthesia and sleep. Br J Anaesth 2022; 128:1006–1018
2.
Chow HS, Hack LM, Kawai M, et al: Anesthetic-induced intraoperative dream associated with remission of a psychiatric disorder: a case report. A A Pract 2022; 16:e01613
3.
Leslie K, Sleigh J, Paech MJ, et al: Dreaming and electroencephalographic changes during anesthesia maintained with propofol or desflurane. Anesthesiology 2009; 111:547–555
4.
Tolly B, Waly A, Peterson G, et al: Adult emergence agitation: a veteran-focused narrative review. Anesth Analg 2021; 132:353–364
5.
Brice DD, Hetherington RR, Utting JE: A simple study of awareness and dreaming during anaesthesia. Br J Anaesth 1970; 42:535–542
6.
Levin R, Nielsen TA: Disturbed dreaming, posttraumatic stress disorder, and affect distress: a review and neurocognitive model. Psychol Bull. 2007; 133:482–528

Information & Authors

Information

Published In

Go to American Journal of Psychiatry
Go to American Journal of Psychiatry
American Journal of Psychiatry
Pages: 563 - 564
PubMed: 38476046

History

Received: 5 September 2023
Revision received: 12 December 2023
Accepted: 3 January 2024
Published online: 13 March 2024
Published in print: June 01, 2024

Keywords

  1. Posttraumatic Stress Disorder (PTSD)
  2. Psychopharmacology

Authors

Details

Laura M. Hack, M.D., Ph.D.
Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, Calif. (Hack, Kawai, Heifets); Sierra Pacific Mental Illness Research, Education, and Clinical Center (MIRECC), VA Palo Alto Health Care System, Palo Alto, Calif. (Hack, Kawai); Department of Psychology, Stanford University, Stanford, Calif. (Sikka); Department of Psychology, University of Turku, Turku, Finland (Sikka); Department of Cognitive Neuroscience and Philosophy, University of Skövde, Skövde, Sweden (Sikka); Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine, Stanford, Calif. (Sikka, Zhou, Chow, Heifets).
Pilleriin Sikka, Ph.D.
Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, Calif. (Hack, Kawai, Heifets); Sierra Pacific Mental Illness Research, Education, and Clinical Center (MIRECC), VA Palo Alto Health Care System, Palo Alto, Calif. (Hack, Kawai); Department of Psychology, Stanford University, Stanford, Calif. (Sikka); Department of Psychology, University of Turku, Turku, Finland (Sikka); Department of Cognitive Neuroscience and Philosophy, University of Skövde, Skövde, Sweden (Sikka); Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine, Stanford, Calif. (Sikka, Zhou, Chow, Heifets).
Kelly Zhou, D.N.P., C.R.N.A.
Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, Calif. (Hack, Kawai, Heifets); Sierra Pacific Mental Illness Research, Education, and Clinical Center (MIRECC), VA Palo Alto Health Care System, Palo Alto, Calif. (Hack, Kawai); Department of Psychology, Stanford University, Stanford, Calif. (Sikka); Department of Psychology, University of Turku, Turku, Finland (Sikka); Department of Cognitive Neuroscience and Philosophy, University of Skövde, Skövde, Sweden (Sikka); Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine, Stanford, Calif. (Sikka, Zhou, Chow, Heifets).
Makoto Kawai, M.D.
Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, Calif. (Hack, Kawai, Heifets); Sierra Pacific Mental Illness Research, Education, and Clinical Center (MIRECC), VA Palo Alto Health Care System, Palo Alto, Calif. (Hack, Kawai); Department of Psychology, Stanford University, Stanford, Calif. (Sikka); Department of Psychology, University of Turku, Turku, Finland (Sikka); Department of Cognitive Neuroscience and Philosophy, University of Skövde, Skövde, Sweden (Sikka); Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine, Stanford, Calif. (Sikka, Zhou, Chow, Heifets).
Harrison S. Chow, M.D.
Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, Calif. (Hack, Kawai, Heifets); Sierra Pacific Mental Illness Research, Education, and Clinical Center (MIRECC), VA Palo Alto Health Care System, Palo Alto, Calif. (Hack, Kawai); Department of Psychology, Stanford University, Stanford, Calif. (Sikka); Department of Psychology, University of Turku, Turku, Finland (Sikka); Department of Cognitive Neuroscience and Philosophy, University of Skövde, Skövde, Sweden (Sikka); Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine, Stanford, Calif. (Sikka, Zhou, Chow, Heifets).
Boris Heifets, M.D., Ph.D. [email protected]
Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, Calif. (Hack, Kawai, Heifets); Sierra Pacific Mental Illness Research, Education, and Clinical Center (MIRECC), VA Palo Alto Health Care System, Palo Alto, Calif. (Hack, Kawai); Department of Psychology, Stanford University, Stanford, Calif. (Sikka); Department of Psychology, University of Turku, Turku, Finland (Sikka); Department of Cognitive Neuroscience and Philosophy, University of Skövde, Skövde, Sweden (Sikka); Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine, Stanford, Calif. (Sikka, Zhou, Chow, Heifets).

Notes

Send correspondence to Dr. Heifets ([email protected]).

Author Contributions

Dr. Hack and Dr. Sikka are equal first authors.

Author Contributions

Dr. Chow and Dr. Heifets are equal senior authors.

Competing Interests

The authors report no financial relationships with commercial interests.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

View Options

View options

PDF/EPUB

View PDF/EPUB

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share